Showing 1,621 - 1,640 results of 226,717 for search '(( 50 ((ng decrease) OR (mean decrease)) ) OR ( 10 ((teer decrease) OR (a decrease)) ))', query time: 1.58s Refine Results
  1. 1621
  2. 1622

    VRK1 overexpression is seen in human breast cancer and is associated with decreased relapse-free survival. by Aye M. Mon (5714912)

    Published 2018
    “…VRK1 score was determined by multiplying the VRK1 staining intensity × percentage of VRK1 positive staining. <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0203397#pone.0203397.g008" target="_blank">Fig 8A</a> includes the data from all primary tumor and lymph node samples. …”
  3. 1623
  4. 1624
  5. 1625
  6. 1626
  7. 1627
  8. 1628
  9. 1629
  10. 1630
  11. 1631
  12. 1632
  13. 1633
  14. 1634
  15. 1635
  16. 1636
  17. 1637
  18. 1638

    Mast cell density and tactile sensitivity decreased after 10 preventative imatinib treatments followed by repeated MI challenges. by Jaclyn M. Kline (9565161)

    Published 2020
    “…<p>For preventative imatinib treatment, mice were treated with 100 μL of 30 mg/kg imatinib dissolved in 0.9% saline injected intraperitoneally 30 minutes before each of 10 daily MI challenges. (A) Density of avidin<sup>+</sup> mast cells in 10 μm labiar skin cryo-sections from sensitized mice receiving NT or preventatively treated with imatinib and challenged 10 times daily with MI. …”
  19. 1639
  20. 1640

    A targeted RNAi screen identifies 17 RNAi candidates that decrease the prolonged lifespan of the METC mutant <i>isp-1;ctb-1</i> by at least 10%. by Ludivine Walter (216669)

    Published 2011
    “…Among them, 13 represent transcription factors not previously known to function in aging and four (indicated with asterisks) are transcription factors already known to affect lifespan in <i>C. elegans</i>: HSF-1 <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.1001084#pbio.1001084-Hsu1" target="_blank">[31]</a>, NHR-49 <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.1001084#pbio.1001084-VanGilst1" target="_blank">[32]</a>, DAF-16 <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.1001084#pbio.1001084-Kenyon1" target="_blank">[33]</a>, and PHA-4 <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.1001084#pbio.1001084-Panowski1" target="_blank">[34]</a>. …”